Adaptimmune Therapeutics
Established in 2008, Adaptimmune LLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary T-cell receptor platform in the treatment of cancer. Headquarters is located in Philadelphia, Pennsylvania.
Last updated on
About Adaptimmune Therapeutics
Founded
2008Estimated Revenue
$10M-$50MEmployees
251-1KFunding / Mkt. Cap
$486MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
87NAICs Code
32Location
City
AbingdonState
OxfordshireCountry
United KingdomTech Stack (78)
